EligibleTrials

The Role of mGluR5 in CBT-I

Recruiting · NCT07076342 · Interventional (participants receive a specific treatment)

View the official record on ClinicalTrials.gov →
Depression

Interventions studied

Cognitive Behavioral Therapy for InsomniaPET Scan with [11C]ABP688

What this trial is about

This is mechanistic clinical trial that evaluates the role of one of the glutamate receptors (mGluR5) in cognitive behavioral therapy for insomnia (CBT-I) as a common pathway in improving sleep and depression.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.